Adenosine reduces postbypass transfusion requirements in humans after heart surgery

Annals of Surgery

Volumn 224, Issue 4, 1996, Pages 523-530

  Mentzer Jr , Robert M ^a   Rahko, Peter S ^a   Canver, Charles C ^a   Chopra, Paramjeet S ^a   Love, Robert B ^a   Cook, Thomas D ^a   Hegge, Julia O ^a   Lasley, Robert D ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; HEPARIN; PLACEBO;

ADULT; ARTICLE; BLOOD TRANSFUSION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART PROTECTION; HEART SURGERY; HEART VALVE REPLACEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE FUNCTION;

ADENOSINE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHEST TUBES; FEMALE; HEART ARREST, INDUCED; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE;

EID: 10144247894     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199610000-00010     Document Type: Article

References (19)

1. Hardy J-F, Desroches J. Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth 1992; 39:353-365.
2. Ferraris VA, Ferraris SP. Limiting excessive postoperative blood transfusion after cardiac procedures: a review. Tex Heart Inst J 1995; 22:216-230.
3. Cosgrove DM, Heric B, Lytle BW, et al. Aprotinin therapy for reoperative myocardial revascularization. Ann Thorac Surg 1992; 54:1031-1038.
4. Levy JH, Pifarre R, Schaff HV, et al. A multicenter, double blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 1995; 92:2236-2244.
5. Born GVR. Aggregation of blood products by adenosine diphosphate and its reversal. Nature 1962; 194:927-929.
6. Agarwal KC. Modulation of platelet functions by plasma adenosine. In: Imai S, Nakazawa M, eds. Role of Adenosine and Adenine Nucleotides in the Biological System. Amsterdam: Elsevier Science Publishers; 1991:457-468.
7. Soderback U, Sollevi A, Wallen NH, et al. Anti-aggregatory effects of physiological concentrations of adenosine in human whole blood as assessed by filtragometry. Clin Sci 1991; 81:691-694.
8. Randhawa MPS Jr, Lasley RD, Mentzer RM Jr. Salutary effects of exogenous adenosine on canine myocardial stunning in vivo, J Thorac Cardiovasc Surg 1995; 110:63-74.
9. Harker LA, Bleeding after cardiopulmonary bypass. N Engl J Med 1986; 314:1446-1448.
10. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990; 76:1680-1697.
11. von Oeverer W, Harder HP, Pouzendaal KJ, et al. Aprotinin protects platelets against initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99:788-797.
12. Rinder CS, Bohnert S, Rinder HM, et al. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 1991; 75:388-393.
13. Belardinelli L, Linden J, Berne RM. The cardiac actions of adenosine. Prog Cardiovasc Dis 1989; 32:73-97.
14. Lasley RD, Bünger R, Mentzer RM Jr. Receptor-mediated and metabolic effects of adenosine in ischemic and postischemic myocardium. In: Belardinelli L, Pelleg A, eds. Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology. Boston, MA: Kluwer Academic Publishers; 1994: 351-360.
15. Mentzer RM Jr, Canver CC, Chopra PS, et al. Efficacy of adenosine as an additive to blood cardioplegia in humans during openheart surgery. Circulation 1995; 92(suppl I):I-762.
16. Gresele P, Arnout J, Ceckmyn H, Vermylen J. Mechanism of the antiplatelet action of the dipyridamole in whole blood: modulation of adenosine concentration and activity. Thromb Haemost 1986; 55:12-18.
17. Beukers MW, Kerkhof CJ, Izerman AP, Soudijn W. Nucleoside transport inhibition and platelet aggregation in human blood: R75231 and its enantiomers, draflazine and R88016. Eur J Pharmacol 1994; 266:57-62.
18. Sollevi A, Torssell L, Fredholm BB, et al. Adenosine spares platelets during cardiopulmonary bypass in man without causing systemic vasodilatation. Scand J Thorac Cardiovasc Surg 1985; 19:155-159.
19. Teoh KH, Christakis GT, Weisel RD, et al. Dipyridamole-preserved platelets and reduced blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1988; 96:332-341.